Key result
This review discusses the risk factors for saphenous vein graft disease after CABG, such as surgery-related factors, smoking, and diabetes, along with current surgical and pharmacologic therapies.
This review summarizes the risk factors, prevention, and treatment strategies for saphenous vein graft disease following coronary artery bypass grafting.
Saphenous vein graft disease (SVGD) is a type of vascular disease that may develop after coronary artery bypass grafting (CABG). SVGD seriously affects the short-term and long-term effects of CABG and increases the incidence of major adverse cardiovascular events. It is very important to identify patients at greatest risk and carry out prevention and treatment measures to determine the risk factors for SVGD. Many factors contribute to SVGD when the vein is grafted into an arterial environment, such as surgery-related factors, smoking, diabetes mellitus, hyperlipidemia, and others. In this review, we discuss the risk factors for SVGD, current surgical and pharmacologic therapies with which to manage SVGD, and the prevention of SVGD.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2018) conducted a review in Saphenous vein graft disease after coronary artery bypass grafting. Surgical and pharmacologic therapies was evaluated. This review discusses the risk factors for saphenous vein graft disease after CABG, such as surgery-related factors, smoking, and diabetes, along with current surgical and pharmacologic therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: